{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:45:46Z","timestamp":1790358346612,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006477","name":"National Taiwan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006477","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003711","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["100-2325-B-002 -003"],"award-info":[{"award-number":["100-2325-B-002 -003"]}],"id":[{"id":"10.13039\/501100003711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003711","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["101-2325-B-002 -004"],"award-info":[{"award-number":["101-2325-B-002 -004"]}],"id":[{"id":"10.13039\/501100003711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003711","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["102-2325-B-002 -004"],"award-info":[{"award-number":["102-2325-B-002 -004"]}],"id":[{"id":"10.13039\/501100003711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003711","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["103-2314-B-002-191-MY3"],"award-info":[{"award-number":["103-2314-B-002-191-MY3"]}],"id":[{"id":"10.13039\/501100003711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["NTUH 106-S3495"],"award-info":[{"award-number":["NTUH 106-S3495"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Science Committee of Taiwan","award":["100-2319-B-001-002"],"award-info":[{"award-number":["100-2319-B-001-002"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","cancerletters.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.canlet.2018.03.032","type":"journal-article","created":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T04:14:42Z","timestamp":1522124082000},"page":"152-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation"],"prefix":"10.1016","volume":"425","author":[{"given":"Yu-Li","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Cheng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Cheng","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nai-Yun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-An","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Zen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Fang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2018.03.032_bib1","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1016\/j.semcancer.2015.02.007","article-title":"Cancer prevention and therapy through the modulation of the tumor microenvironment","volume":"35","author":"Casey","year":"2015","journal-title":"Semin. Canc. Biol."},{"key":"10.1016\/j.canlet.2018.03.032_bib2","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2018.03.032_bib3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev.iy.12.040194.002005","article-title":"Tumor antigens recognized by T lymphocytes","volume":"12","author":"Boon","year":"1994","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.canlet.2018.03.032_bib4","first-page":"687","article-title":"Immune based therapies in cancer","volume":"22","author":"Kruger","year":"2007","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.canlet.2018.03.032_bib5","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/00001574-200211000-00015","article-title":"Update on cancer vaccines","volume":"18","author":"Borges","year":"2002","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.canlet.2018.03.032_bib6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nri1592","article-title":"Dendritic cells as therapeutic vaccines against cancer","volume":"5","author":"Banchereau","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2018.03.032_bib7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1042\/BJ20110282","article-title":"Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK\/ERK and JNK pathways","volume":"442","author":"Chang","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.canlet.2018.03.032_bib8","first-page":"3862","article-title":"Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE)","volume":"7","author":"Argani","year":"2001","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2018.03.032_bib9","first-page":"889","article-title":"Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes","volume":"61","author":"Hippo","year":"2001","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2018.03.032_bib10","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0046-8177(03)00177-1","article-title":"Large-scale molecular and tissue microarray analysis of mesothelin expression in common human carcinomas","volume":"34","author":"Frierson","year":"2003","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.canlet.2018.03.032_bib11","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1158\/1078-0432.CCR-03-0801","article-title":"Mesothelin: a new target for immunotherapy","volume":"10","author":"Hassan","year":"2004","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2018.03.032_bib12","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1042\/BJ20082196","article-title":"Mesothelin inhibits paclitaxel-induced apoptosis through the PI3K pathway","volume":"424","author":"Chang","year":"2009","journal-title":"Biochem. J."},{"key":"10.1016\/j.canlet.2018.03.032_bib13","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.clbc.2013.05.001","article-title":"Mesothelin expression and survival outcomes in triple receptor negative breast cancer","volume":"13","author":"Parinyanitikul","year":"2013","journal-title":"Clin. Breast Canc."},{"key":"10.1016\/j.canlet.2018.03.032_bib14","first-page":"4721","article-title":"Serum mesothelin in epithelial ovarian carcinoma: a new screening marker and prognostic factor","volume":"26","author":"Huang","year":"2006","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2018.03.032_bib15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/bjc.2012.235","article-title":"Luminal membrane expression of mesothelin is a prominent poor prognostic factor for gastric cancer","volume":"107","author":"Einama","year":"2012","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.canlet.2018.03.032_bib16","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1083\/jcb.114.6.1285","article-title":"Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10","volume":"114","author":"Bradham","year":"1991","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.canlet.2018.03.032_bib17","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1128\/MCB.19.4.2958","article-title":"Fisp12\/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in\u00a0vivo","volume":"19","author":"Babic","year":"1999","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2018.03.032_bib18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1600-0560.1998.tb01706.x","article-title":"Differential expression of connective tissue growth factor gene in cutaneous fibrohistiocytic and vascular tumors","volume":"25","author":"Igarashi","year":"1998","journal-title":"J.\u00a0Cutan. Pathol."},{"key":"10.1016\/j.canlet.2018.03.032_bib19","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/gt.2008.25","article-title":"Connective tissue growth factor linked to the E7 tumor antigen generates potent antitumor immune responses mediated by an antiapoptotic mechanism","volume":"15","author":"Cheng","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.canlet.2018.03.032_bib20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/14760584.2018.1434000","article-title":"Current challenges for cancer vaccine adjuvant development","volume":"17","author":"Bowen","year":"2018","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.canlet.2018.03.032_bib21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/gt.2015.85","article-title":"Mesothelin-specific cell-based vaccine generates antigen-specific immunity and potent antitumor effects by combining with IL-12 immunomodulator","volume":"23","author":"Chang","year":"2016","journal-title":"Gene Ther."},{"key":"10.1016\/j.canlet.2018.03.032_bib22","first-page":"157","article-title":"Anti-CD40 antibody and toll-like receptor 3 ligand restore dendritic cell-mediated anti-tumor immunity suppressed by morphine","volume":"6","author":"Chang","year":"2016","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.canlet.2018.03.032_bib23","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/cncr.22781","article-title":"Generation and characterization of an ascitogenic mesothelin-expressing tumor model","volume":"110","author":"Cheng","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2018.03.032_bib24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/016173460702900401","article-title":"Noninvasive tumor imaging with high-frequency ultrasound and microPET in small animals","volume":"29","author":"Liao","year":"2007","journal-title":"Ultrason. Imag."},{"key":"10.1016\/j.canlet.2018.03.032_bib25","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/sj.gt.3302974","article-title":"Control of human mesothelin-expressing tumors by DNA vaccines","volume":"14","author":"Chang","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.canlet.2018.03.032_bib26","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.immuni.2012.03.027","article-title":"GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cells","volume":"36","author":"Greter","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2018.03.032_bib27","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.molonc.2011.11.010","article-title":"Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response","volume":"6","author":"Chen","year":"2012","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.canlet.2018.03.032_bib28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.canlet.2015.01.007","article-title":"Insulin-like growth factors inhibit dendritic cell-mediated anti-tumor immunity through regulating ERK1\/2 phosphorylation and p38 dephosphorylation","volume":"359","author":"Huang","year":"2015","journal-title":"Canc. Lett."},{"key":"10.1016\/j.canlet.2018.03.032_bib29","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.bbrc.2012.08.096","article-title":"Green tea polyphenol epigallocatechin-3-gallate inhibits TLR4 signaling through the 67-kDa laminin receptor on lipopolysaccharide-stimulated dendritic cells","volume":"426","author":"Byun","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2018.03.032_bib30","article-title":"Novel mechanism of inhibition of dendritic cells maturation by mesenchymal stem cells via interleukin-10 and the JAK1\/STAT3 signaling pathway","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2018.03.032_bib31","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ymthe.2017.11.011","article-title":"Irradiation enhances abscopal anti-tumor effects of antigen-specific immunotherapy through regulating tumor microenvironment","volume":"26","author":"Chang","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.canlet.2018.03.032_bib32","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1002\/1521-4141(200208)32:8<2255::AID-IMMU2255>3.0.CO;2-A","article-title":"Phenotypic analysis of the murine CD4-related glycoprotein, CD223 (LAG-3)","volume":"32","author":"Workman","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.canlet.2018.03.032_bib33","article-title":"Depletion of regulatory T lymphocytes reverses the imbalance between pro- and anti-tumor immunities via enhancing antigen-specific T cell immune responses","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2018.03.032_bib34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/0394632016681306","article-title":"Cytokine profiles of tumor supernatants in invasive ductal cancer and fibroadenoma of the breast and its relationship with VEGF-A expression in the tumors","volume":"30","author":"Autenshlyus","year":"2017","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.canlet.2018.03.032_bib35","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1200\/JCO.2016.68.3672","article-title":"Mesothelin immunotherapy for cancer: ready for prime time?","volume":"34","author":"Hassan","year":"2016","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.canlet.2018.03.032_bib36","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1172\/JCI200112346","article-title":"Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen","volume":"108","author":"Cheng","year":"2001","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.canlet.2018.03.032_bib37","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.canlet.2017.01.040","article-title":"Metronomic chemotherapy and immunotherapy in cancer treatment","volume":"400","author":"Chen","year":"2017","journal-title":"Canc. Lett."},{"issue":"2011","key":"10.1016\/j.canlet.2018.03.032_bib38","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature10673","article-title":"Cancer immunotherapy comes of age","volume":"480","author":"Mellman","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2018.03.032_bib39","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.immuni.2010.10.007","article-title":"Designing vaccines based on biology of human dendritic cell subsets","volume":"33","author":"Palucka","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2018.03.032_bib40","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1084\/jem.20090746","article-title":"Nussenzweig, Feedback control of regulatory T cell homeostasis by dendritic cells in\u00a0vivo","volume":"206","author":"Darrasse-J\u00e8ze","year":"2009","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.canlet.2018.03.032_bib41","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.immuni.2007.08.015","article-title":"Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation","volume":"27","author":"Jiang","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2018.03.032_bib42","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1084\/jem.191.3.411","article-title":"The induction of tolerance by dendritic cells that have captured apoptotic cells","volume":"191","author":"Steinman","year":"2000","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.canlet.2018.03.032_bib43","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1146\/annurev.immunol.21.120601.141040","article-title":"Tolerogenic dendritic cells","volume":"21","author":"Steinman","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.canlet.2018.03.032_bib44","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1084\/jem.20031591","article-title":"Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN","volume":"199","author":"Ahonen","year":"2004","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.canlet.2018.03.032_bib45","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/jnci\/94.11.805","article-title":"Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?","volume":"94","author":"Parmiani","year":"2002","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2018.03.032_bib46","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nri1150","article-title":"Cancer vaccines: between the idea and the reality","volume":"3","author":"Finn","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2018.03.032_bib47","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1158\/2326-6066.CIR-15-0064","article-title":"The interplay of immunotherapy and chemotherapy: harnessing potential synergies","volume":"3","author":"Emens","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.canlet.2018.03.032_bib48","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/j.seminoncol.2015.09.016","article-title":"Understanding the rationale for immunotherapy in non-small cell lung cancer","volume":"42","author":"Pennell","year":"2015","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.canlet.2018.03.032_bib49","first-page":"7","article-title":"An overview on immunomodulation","volume":"3","author":"Saroj","year":"2012","journal-title":"J.\u00a0Adv. Sci. Res."},{"key":"10.1016\/j.canlet.2018.03.032_bib50","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/intimm\/dxw015","article-title":"Vaccine adjuvants as potential cancer immunotherapeutics","volume":"28","author":"Temizoz","year":"2016","journal-title":"Int. Immunol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383518302295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383518302295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T00:29:45Z","timestamp":1534984185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383518302295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":50,"alternative-id":["S0304383518302295"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2018.03.032","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2018.03.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}